I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Hemostasis
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Hemostasis Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Hemostasis Diagnostics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Laboratory Systems
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Laboratory Systems by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Laboratory Systems by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Point-of-Care
Testing Systems by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Point-of-Care Testing
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Point-of-Care Testing
Systems by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 13: World Current & Future Analysis for Hospital/Clinics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Hospital/Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Hospital/Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Independent
Diagnostic Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Independent Diagnostic
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Independent Diagnostic
Laboratories by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 19: World Current & Future Analysis for Home Care
Settings by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Home Care Settings by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Home Care Settings by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 25: USA Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Hemostasis Diagnostics by
Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 28: USA Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 29: USA Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for Hemostasis Diagnostics by
End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

CANADA
Table 31: Canada Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 34: Canada Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 35: Canada Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

JAPAN
Table 37: Japan Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 40: Japan Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 41: Japan Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

CHINA
Table 43: China Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 46: China Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 47: China Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

EUROPE
Table 49: Europe Current & Future Analysis for Hemostasis
Diagnostics by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 50: Europe Historic Review for Hemostasis Diagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Hemostasis Diagnostics
by Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 56: Europe Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

FRANCE
Table 58: France Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 61: France Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: France Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

GERMANY
Table 64: Germany Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 65: Germany Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Hemostasis
Diagnostics by Product - Percentage Breakdown of Value Sales
for Laboratory Systems, Consumables and Point-of-Care Testing
Systems for the Years 2012, 2020 & 2027

Table 67: Germany Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 68: Germany Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for Hemostasis
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

ITALY
Table 70: Italy Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 73: Italy Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: Italy Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 76: UK Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Hemostasis Diagnostics by
Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 79: UK Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for Hemostasis Diagnostics by
End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

SPAIN
Table 82: Spain Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 83: Spain Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 84: Spain 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 85: Spain Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 86: Spain Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: Spain 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

RUSSIA
Table 88: Russia Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 89: Russia Historic Review for Hemostasis Diagnostics by
Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: Russia 15-Year Perspective for Hemostasis Diagnostics
by Product - Percentage Breakdown of Value Sales for Laboratory
Systems, Consumables and Point-of-Care Testing Systems for the
Years 2012, 2020 & 2027

Table 91: Russia Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 92: Russia Historic Review for Hemostasis Diagnostics by
End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 93: Russia 15-Year Perspective for Hemostasis Diagnostics
by End-Use - Percentage Breakdown of Value Sales for
Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

REST OF EUROPE
Table 94: Rest of Europe Current & Future Analysis for
Hemostasis Diagnostics by Product - Laboratory Systems,
Consumables and Point-of-Care Testing Systems - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 95: Rest of Europe Historic Review for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 96: Rest of Europe 15-Year Perspective for Hemostasis
Diagnostics by Product - Percentage Breakdown of Value Sales
for Laboratory Systems, Consumables and Point-of-Care Testing
Systems for the Years 2012, 2020 & 2027

Table 97: Rest of Europe Current & Future Analysis for
Hemostasis Diagnostics by End-Use - Hospital/Clinics,
Independent Diagnostic Laboratories, Home Care Settings and
Other End-Uses - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Hemostasis
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

ASIA-PACIFIC
Table 100: Asia-Pacific Current & Future Analysis for
Hemostasis Diagnostics by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 101: Asia-Pacific Historic Review for Hemostasis
Diagnostics by Geographic Region - Australia, India, South
Korea and Rest of Asia-Pacific Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 102: Asia-Pacific 15-Year Perspective for Hemostasis
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 103: Asia-Pacific Current & Future Analysis for
Hemostasis Diagnostics by Product - Laboratory Systems,
Consumables and Point-of-Care Testing Systems - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 104: Asia-Pacific Historic Review for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 105: Asia-Pacific 15-Year Perspective for Hemostasis
Diagnostics by Product - Percentage Breakdown of Value Sales
for Laboratory Systems, Consumables and Point-of-Care Testing
Systems for the Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for
Hemostasis Diagnostics by End-Use - Hospital/Clinics,
Independent Diagnostic Laboratories, Home Care Settings and
Other End-Uses - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 107: Asia-Pacific Historic Review for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Hemostasis
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospital/Clinics, Independent Diagnostic Laboratories, Home
Care Settings and Other End-Uses for the Years 2012, 2020 &
2027

AUSTRALIA
Table 109: Australia Current & Future Analysis for Hemostasis
Diagnostics by Product - Laboratory Systems, Consumables and
Point-of-Care Testing Systems - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: Australia Historic Review for Hemostasis Diagnostics
by Product - Laboratory Systems, Consumables and Point-of-Care
Testing Systems Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 111: Australia 15-Year Perspective for Hemostasis
Diagnostics by Product - Percentage Breakdown of Value Sales
for Laboratory Systems, Consumables and Point-of-Care Testing
Systems for the Years 2012, 2020 & 2027

Table 112: Australia Current & Future Analysis for Hemostasis
Diagnostics by End-Use - Hospital/Clinics, Independent
Diagnostic Laboratories, Home Care Settings and Other End-Uses -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 113: Australia Historic Review for Hemostasis Diagnostics
by End-Use - Hospital/Clinics, Independent Diagnostic
Laboratories, Home Care Settings and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 114: Australia 15-Year Perspective for Hemostasis
Diagnostics by End-Use - Percentage Breakdown of Value Sales
for Hospital/Clinics, In